WTTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WTTR is not a good buy right now for an impatient buyer. The chart setup is mildly bullish (trend up, MACD positive), and options open interest leans bullish, but the latest quarter showed sharp YoY deterioration (revenue, margins, EPS), there are no Intellectia buy signals today, and the similar-pattern forward read flags elevated 1-month downside risk (-8.65%). At $11.97, I’d avoid initiating here unless it cleanly breaks and holds above ~$12.49; otherwise the better entry is closer to support ($11.46).
Trend/Setup: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend intact). MACD histogram is slightly above zero and expanding, supporting continued upside momentum. RSI(6) ~61.6 = neutral-to-mildly bullish (not overbought). Key levels: Pivot ~11.98 (price is sitting right on it, so direction is not confirmed). Support: 11.46 then 11.14. Resistance: 12.49 then 12.81. A decisive move above 12.49 would confirm breakout potential; losing 11.46 increases risk of a deeper pullback. Pattern-based odds: Similar-candlestick study suggests ~40% chance of -0.26% next day, +0.38% next week, but -8.65% next month—near-term chop with weaker 1-month expectancy.
Intellectia Proprietary Trading Signals
showed steep YoY deterioration in revenue, margins, and profitability.
Latest quarter: 2025/Q3. Revenue fell to $322.243M (-13.22% YoY). Net income dropped to $2.683M (-83.01% YoY). EPS was $0.03 (-80% YoY). Gross margin declined to 13.11% (-21.21% YoY). Overall, growth and profitability trends weakened materially, which limits how aggressively to buy even with a constructive chart.
Recent Street trend is mixed: Northland downgraded to Market Perform with a $12 target (valuation viewed as reasonable), while Citi reiterated Buy and raised PT to $15, and Raymond James reiterated Strong Buy and raised PT to $16 after generally solid results/guide. Most recently, Piper Sandler kept Overweight but trimmed PT from $15 to $14. Wall St pros: Multiple bullish ratings and targets above current price; expectation of cyclical tailwinds and recovery potential. Wall St cons: Downgrade on valuation, and the bull case depends on improved FY26 EBITDA/industry activity; near-term fundamentals have been pressured. Influential/politician activity: No recent congress trading data available; hedge funds and insiders are reported as neutral with no significant recent trend.
